TGF-β induces miR-30d down-regulation and podocyte injury through Smad2/3 and HDAC3-associated transcriptional repression
详细信息 查看全文
- 作者：Lin Liu ; Wenjun Lin ; Qin Zhang ; Wangsen Cao ; Zhihong Liu
- 关键词：TGF ; β ; miR ; 30d ; HDAC3 ; Smad ; Podocyte ; Transcriptional repression
- 刊名：Journal of Molecular Medicine
- 出版年：2016
- 出版时间：March 2016
- 年：2016
- 卷：94
- 期：3
- 页码：291-300
- 全文大小：1,356 KB
- 参考文献：1.John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS (2004) Human MicroRNA targets. PLoS Biol 2:e363CrossRef PubMed PubMedCentral
2.Zhao JJ, Lin J, Zhu D, Wang X, Brooks D, Chen M, Chu ZB, Takada K, Ciccarelli B, Admin S et al (2014) miR-30-5p functions as a tumor suppressor and novel therapeutic tool by targeting the oncogenic Wnt/beta-catenin/BCL9 pathway. Cancer Res 74:1801–1813CrossRef PubMed PubMedCentral
3.Kao CJ, Martiniez A, Shi XB, Yang J, Evans CP, Dobi A, deVere WRW, Kung HJ (2014) miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT. Oncogene 33:2495–2503CrossRef PubMed PubMedCentral
4.Zaragosi LE, Wdziekonski B, Brigand KL, Villageois P, Mari B, Waldmann R, Dani C, Barbry P (2011) Small RNA sequencing reveals miR-642a-3p as a novel adipocyte-specific microRNA and miR-30 as a key regulator of human adipogenesis. Genome Biol 12:R64CrossRef PubMed PubMedCentral
5.Wu J, Zheng C, Fan Y, Zeng C, Chen Z, Qin W, Zhang C, Zhang W, Wang X, Zhu X et al (2014) Downregulation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids. JASN 25:92–104CrossRef PubMed PubMedCentral
6.Ketley A, Warren A, Holmes E, Gering M, Aboobaker AA, Brook JD (2013) The miR-30 microRNA family targets smoothened to regulate hedgehog signalling in zebrafish early muscle development. PLoS One 8:e65170CrossRef PubMed PubMedCentral
7.Frederick JP, Liberati NT, Waddell DS, Shi Y, Wang XF (2004) Transforming growth factor beta-mediated transcriptional repression of c-myc is dependent on direct binding of Smad3 to a novel repressive Smad binding element. Mol Cell Biol 24:2546–2559CrossRef PubMed PubMedCentral
8.Xi Q, Wang Z, Zaromytidou AI, Zhang XH, Chow-Tsang LF, Liu JX, Kim H, Barlas A, Manova-Todorova K, Kaartinen V et al (2011) A poised chromatin platform for TGF-beta access to master regulators. Cell 147:1511–1524CrossRef PubMed PubMedCentral
9.Blahna MT, Hata A (2012) Smad-mediated regulation of microRNA biosynthesis. FEBS Lett 586:1906–1912CrossRef PubMed PubMedCentral
10.Kato M, Putta S, Wang M, Yuan H, Lanting L, Nair I, Gunn A, Nakagawa Y, Shimano H, Todorov I et al (2009) TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat Cell Biol 11:881–889CrossRef PubMed PubMedCentral
11.Khan SN, Khan AU (2010) Role of histone acetylation in cell physiology and diseases: an update. Clin Chim Acta; Intl J Clin Chem 411:1401–1411CrossRef
12.Shahbazian MD, Grunstein M (2007) Functions of site-specific histone acetylation and deacetylation. Annu Rev Biochem 76:75–100CrossRef PubMed
13.Oberoi J, Fairall L, Watson PJ, Yang JC, Czimmerer Z, Kampmann T, Goult BT, Greenwood JA, Gooch JT, Kallenberger BC et al (2011) Structural basis for the assembly of the SMRT/NCoR core transcriptional repression machinery. Nat Struct Mol Biol 18:177–184CrossRef PubMed PubMedCentral
14.Zhang S, Cai X, Huang F, Zhong W, Yu Z (2008) Effect of trichostatin a on viability and microRNA expression in human pancreatic cancer cell line BxPC-3. Exp Oncol 30:265–268PubMed
15.Scott GK, Mattie MD, Berger CE, Benz SC, Benz CC (2006) Rapid alteration of microRNA levels by histone deacetylase inhibition. Cancer Res 66:1277–1281CrossRef PubMed
16.Chen DQ, Pan BZ, Huang JY, Zhang K, Cui SY, De W, Wang R, Chen LB (2014) HDAC 1/4-mediated silencing of microRNA-200b promotes chemoresistance in human lung adenocarcinoma cells. Oncotarget 5:3333–3349CrossRef PubMed PubMedCentral
17.Lodrini M, Oehme I, Schroeder C, Milde T, Schier MC, Kopp-Schneider A, Schulte JH, Fischer M, De Preter K, Pattyn F et al (2013) MYCN and HDAC2 cooperate to repress miR-183 signaling in neuroblastoma. Nucleic Acids Res 41:6018–6033CrossRef PubMed PubMedCentral
18.Zhang X, Chen X, Lin J, Lwin T, Wright G, Moscinski LC, Dalton WS, Seto E, Wright K, Sotomayor E et al (2012) Myc represses miR-15a/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas. Oncogene 31:3002–3008CrossRef PubMed PubMedCentral
19.Wu C, Jin B, Chen L, Zhuo D, Zhang Z, Gong K, Mao Z (2013) MiR-30d induces apoptosis and is regulated by the Akt/FOXO pathway in renal cell carcinoma. Cell Signal 25:1212–1221CrossRef PubMed
20.Saleem MA, O’Hare MJ, Reiser J, Coward RJ, Inward CD, Farren T, Xing CY, Ni L, Mathieson PW, Mundel P (2002) A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. JASN 13:630–638PubMed
21.Yin SS, Cao WS (2015) Toll-like receptor signaling induces Nrf2 pathway activation through p62-Triggered Keap1 degradation. Mol Cell Biol 35:2673–2683CrossRef PubMed PubMedCentral
22.Qi W, Chen X, Holian J, Mreich E, Twigg S, Gilbert RE, Pollock CA (2006) Transforming growth factor-beta1 differentially mediates fibronectin and inflammatory cytokine expression in kidney tubular cells. Am J Physiol Renal Physiol 291:F1070–1077CrossRef PubMed
23.Wotton D, Lo RS, Swaby LA, Massague J (1999) Multiple modes of repression by the Smad transcriptional corepressor TGIF. J Biol Chem 274:37105–37110CrossRef PubMed
24.Long J, Matsuura I, He D, Wang G, Shuai K, Liu F (2003) Repression of Smad transcriptional activity by PIASy, an inhibitor of activated STAT. Proc Natl Acad Sci U S A 100:9791–9796CrossRef PubMed PubMedCentral
25.Yuan H, Reddy MA, Sun G, Lanting L, Wang M, Kato M, Natarajan R (2013) Involvement of p300/CBP and epigenetic histone acetylation in TGF-beta1-mediated gene transcription in mesangial cells. Am J Physiol Renal Physiol 304:F601–613CrossRef PubMed PubMedCentral
26.Aarenstrup L, Flindt EN, Otkjaer K, Kirkegaard M, Andersen JS, Kristiansen K (2008) HDAC activity is required for p65/RelA-dependent repression of PPARdelta-mediated transactivation in human keratinocytes. J Invest Dermatol 128:1095–1106CrossRef PubMed
27.Sun Z, Feng D, Fang B, Mullican SE, You SH, Lim HW, Everett LJ, Nabel CS, Li Y, Selvakumaran V et al (2013) Deacetylase-independent function of HDAC3 in transcription and metabolism requires nuclear receptor corepressor. Mol Cell 52:769–782CrossRef PubMed
28.Bantscheff M, Hopf C, Savitski MM, Dittmann A, Grandi P, Michon AM, Schlegl J, Abraham Y, Becher I, Bergamini G et al (2011) Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes. Nat Biotechnol 29:255–265CrossRef PubMed
29.Ozsolak F, Poling LL, Wang Z, Liu H, Liu XS, Roeder RG, Zhang X, Song JS, Fisher DE (2008) Chromatin structure analyses identify miRNA promoters. Genes Dev 22:3172–3183CrossRef PubMed PubMedCentral
30.Chung AC, Huang XR, Meng X, Lan HY (2010) miR-192 mediates TGF-beta/Smad3-driven renal fibrosis. J Am Soc Nephrol: JASN 21:1317–1325CrossRef PubMed PubMedCentral
31.Long X, Miano JM (2011) Transforming growth factor-beta1 (TGF-beta1) utilizes distinct pathways for the transcriptional activation of microRNA 143/145 in human coronary artery smooth muscle cells. J Biol Chem 286:30119–30129CrossRef PubMed PubMedCentral
32.Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A (2010) Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha. Mol Cell 39:373–384CrossRef PubMed PubMedCentral
33.Yu Y, Wang Y, Ren X, Tsuyada A, Li A, Liu LJ, Wang SE (2010) Context-dependent bidirectional regulation of the MutS homolog 2 by transforming growth factor beta contributes to chemoresistance in breast cancer cells. MCR 8:1633–1642CrossRef PubMed PubMedCentral
34.Simonsson M, Kanduri M, Gronroos E, Heldin CH, Ericsson J (2006) The DNA binding activities of Smad2 and Smad3 are regulated by coactivator-mediated acetylation. J Biol Chem 281:39870–39880CrossRef PubMed
35.Chen CR, Kang Y, Siegel PM, Massague J (2002) E2F4/5 and p107 as Smad cofactors linking the TGFbeta receptor to c-myc repression. Cell 110:19–32CrossRef PubMed
36.Nomura T, Khan MM, Kaul SC, Dong HD, Wadhwa R, Colmenares C, Kohno I, Ishii S (1999) Ski is a component of the histone deacetylase complex required for transcriptional repression by Mad and thyroid hormone receptor. Genes Dev 13:412–423CrossRef PubMed PubMedCentral
37.Chen S, El-Dahr SS (2013) Histone deacetylases in kidney development: implications for disease and therapy. Pediatr Nephrol 28:689–698CrossRef PubMed
38.Brilli LL, Swanhart LM, de Caestecker MP, Hukriede NA (2013) HDAC inhibitors in kidney development and disease. Pediatr Nephrol 28:1909–1921CrossRef PubMed PubMedCentral
39.Noh H, Oh EY, Seo JY, Yu MR, Kim YO, Ha H, Lee HB (2009) Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury. Am J Physiol Renal Physiol 297:F729–F739CrossRef PubMed
40.Wang X, Liu J, Zhen J, Zhang C, Wan Q, Liu G, Wei X, Zhang Y, Wang Z, Han H et al (2014) Histone deacetylase 4 selectively contributes to podocyte injury in diabetic nephropathy. Kidney Int 86:712–725CrossRef PubMed
41.Tabata T, Kokura K, Ten Dijke P, Ishii S (2009) Ski co-repressor complexes maintain the basal repressed state of the TGF-beta target gene, SMAD7, via HDAC3 and PRMT5. Genes Cells: Devoted Mol Cell Mech 14:17–28CrossRef - 作者单位：Lin Liu (1)
Wenjun Lin (1)
Qin Zhang (1)
Wangsen Cao (1) (2)
Zhihong Liu (1)
1. National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, 210016, China
2. The Key lab of Jiangsu molecular Medicine, Nanjing University School of Medicine, Nanjing, 210091, China - 刊物类别：Biomedical and Life Sciences
- 刊物主题：Biomedicine
Molecular Medicine
Internal Medicine - 出版者：Springer Berlin / Heidelberg
- ISSN：1432-1440
文摘